{"entity":{"type":"insider","cik":"0001251371","url":"/insider/0001251371","json_url":"/insider/0001251371.json","name":"PELLETIER SAUNDRA L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":12,"first":"2018-08-13","last":"2022-05-31","span_basis":"filed_date"},"name_variants":[{"name":"PELLETIER SAUNDRA L","source":"filing","n_filings":12,"first_seen":"2018-08-13","last_seen":"2022-05-31"}],"transactions":[{"id":6687785,"accession":"0001618835-22-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-22-000130","line_url":"/filing/0001618835-22-000130#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":141000.0,"shares_display":"141,000","price_per_share":0.3525,"price_display":"0.35","price_state":"stated","total_value":49702.5,"total_display":"49,702.50","total_whole":"49,703","shares_owned_after":236722.0,"shares_owned_after_display":"236,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":4646005,"accession":"0001618835-21-000271","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-21-000271","line_url":"/filing/0001618835-21-000271#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":135000.0,"shares_display":"135,000","price_per_share":0.375,"price_display":"0.38","price_state":"stated","total_value":50625.0,"total_display":"50,625.00","total_whole":"50,625","shares_owned_after":985837.0,"shares_owned_after_display":"985,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-20","scope":"insider"},{"id":4940547,"accession":"0001209191-21-048272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048272","line_url":"/filing/0001209191-21-048272#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6545.0,"shares_display":"6,545","price_per_share":3.82,"price_display":"3.82","price_state":"stated","total_value":25001.9,"total_display":"25,001.90","total_whole":"25,002","shares_owned_after":12045.0,"shares_owned_after_display":"12,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-27","scope":"insider"},{"id":5010734,"accession":"0001618835-21-000147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-21-000147","line_url":"/filing/0001618835-21-000147#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":51500.0,"total_display":"51,500.00","total_whole":"51,500","shares_owned_after":850837.0,"shares_owned_after_display":"850,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-10","scope":"insider"},{"id":5418989,"accession":"0001618835-21-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-21-000052","line_url":"/filing/0001618835-21-000052#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45249.0,"shares_display":"45,249","price_per_share":2.28,"price_display":"2.28","price_state":"stated","total_value":103167.72,"total_display":"103,167.72","total_whole":"103,168","shares_owned_after":906137.0,"shares_owned_after_display":"906,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-09","scope":"insider"},{"id":2117201,"accession":"0001618835-20-000218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-20-000218","line_url":"/filing/0001618835-20-000218#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122500.0,"shares_display":"122,500","price_per_share":3.26,"price_display":"3.26","price_state":"stated","total_value":399350.0,"total_display":"399,350.00","total_whole":"399,350","shares_owned_after":360888.0,"shares_owned_after_display":"360,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":3010279,"accession":"0001209191-20-037018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-037018","line_url":"/filing/0001209191-20-037018#line-2","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.0697,"price_display":"2.07","price_state":"stated","total_value":6209.1,"total_display":"6,209.10","total_whole":"6,209","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider"},{"id":3010274,"accession":"0001209191-20-037018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-037018","line_url":"/filing/0001209191-20-037018#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":5000.0,"total_display":"5,000.00","total_whole":"5,000","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-16","scope":"insider"},{"id":2932158,"accession":"0001618835-20-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-20-000010","line_url":"/filing/0001618835-20-000010#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3295.0,"shares_display":"3,295","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":19770.0,"total_display":"19,770.00","total_whole":"19,770","shares_owned_after":362289.0,"shares_owned_after_display":"362,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-13","filed_date":"2020-01-15","scope":"insider"},{"id":2081405,"accession":"0001618835-20-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-20-000004","line_url":"/filing/0001618835-20-000004#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6705.0,"shares_display":"6,705","price_per_share":6.05,"price_display":"6.05","price_state":"stated","total_value":40565.25,"total_display":"40,565.25","total_whole":"40,565","shares_owned_after":365584.0,"shares_owned_after_display":"365,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":8392326,"accession":"0001618835-19-000212","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-19-000212","line_url":"/filing/0001618835-19-000212#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":146000.0,"total_display":"146,000.00","total_whole":"146,000","shares_owned_after":372289.0,"shares_owned_after_display":"372,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":8392321,"accession":"0001618835-19-000184","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001618835-19-000184","line_url":"/filing/0001618835-19-000184#line-2","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.01,"price_display":"6.01","price_state":"stated","total_value":60100.0,"total_display":"60,100.00","total_whole":"60,100","shares_owned_after":414676.0,"shares_owned_after_display":"414,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-21","filed_date":"2019-11-21","scope":"insider"},{"id":6429074,"accession":"0001618835-18-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-18-000083","line_url":"/filing/0001618835-18-000083#line-1","is_derivative":false,"issuer_cik":"0001251371","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001251371","owner_cik":"0001251371","owner_name":"PELLETIER SAUNDRA L","owner_display_name":"PELLETIER SAUNDRA L","owner_url":"/insider/0001251371","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":21100.0,"total_display":"21,100.00","total_whole":"21,100","shares_owned_after":341813.0,"shares_owned_after_display":"341,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001618835","name":"Evofem Biosciences, Inc.","url":"/issuer/0001618835","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2018-08-13","last_seen":"2022-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Director","n_filings":2,"first_seen":"2020-06-16","last_seen":"2021-07-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001251371","retrieved_at":"2026-08-25T11:30:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}